Abstract
We previously demonstrated that abnormal nipple aspirate fluid (NAF) cytology predicted residual breast cancer (RC) and tumour size after excisional biopsy (EB), although normal NAF cytology did not exclude RC. Tumour size correlates with the risk of lymph node (LN) metastases. LN metastases provide prognostic information allowing medical and radiation oncologists to determine the need for adjuvant therapy. We hypothesized that pathologic factors known after EB, combined with NAF cytology, would predict with a high degree of accuracy the presence of RC and LN spread. NAF cytology and pathologic parameters: tumour distance from biopsy margins, multifocal and multicentric disease, sub-type of ductal carcinoma in situ (DCIS) or invasive cancer (IC), grade of DCIS or IC, tumour and specimen size, tumour and biopsy cavity location, presence or absence of extensive DCIS, and biopsy scar distance from the nipple were evaluated bivariately and then by logistic regression (LR) for their association with RC and involved LN (≥ 1 (+) LN, useful to determine chemotherapy need, and ≥ 4 (+) LN, useful to determine radiation need to the chest and axilla). Data were analysed using NAF cytology alone, pathologic parameters alone, and NAF cytology and pathologic parameters combined. The combined LR model was superior in predicting residual cancer (94%) to LR models using NAF cytology (36%) or pathologic parameters (75%) alone. When only subjects with normal NAF cytology were evaluated by LR, the model was 92% sensitive in predicting RC. Tumour size and NAF cytology predicted which patients had ≥ 1 (+) LN, whereas tumour and specimen size predicted which patients had ≥ 4 (+) LN. We propose an alogorithm which, if confirmed in a larger study, may allow clinicians to be more selective in their recommendations of re-excision breast biopsy or mastectomy. © 2001 Cancer Research Campaign http://www.bjcancer.com
Keywords: nipple aspirate fluid, mastectomy, biomarkers
Full Text
The Full Text of this article is available as a PDF (57.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gwin J. L., Eisenberg B. L., Hoffman J. P., Ottery F. D., Boraas M., Solin L. J. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg. 1993 Dec;218(6):729–734. doi: 10.1097/00000658-199312000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- King E. B., Barrett D., King M. C., Petrakis N. L. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol. 1975 Dec;64(6):728–738. doi: 10.1093/ajcp/64.6.728. [DOI] [PubMed] [Google Scholar]
- King E. B., Chew K. L., Petrakis N. L., Ernster V. L. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst. 1983 Dec;71(6):1115–1121. [PubMed] [Google Scholar]
- Lagios M. D. Pathologic features related to local recurrence following lumpectomy and irradiation. Semin Surg Oncol. 1992 May-Jun;8(3):122–128. [PubMed] [Google Scholar]
- Petrakis N. L., Mason L., Lee R., Sugimoto B., Pawson S., Catchpool F. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst. 1975 Apr;54(4):829–834. [PubMed] [Google Scholar]
- Sauter E. R., Daly M., Linahan K., Ehya H., Engstrom P. F., Bonney G., Ross E. A., Yu H., Diamandis E. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):967–970. [PubMed] [Google Scholar]
- Sauter E. R., Ehya H., Babb J., Diamandis E., Daly M., Klein-Szanto A., Sigurdson E., Hoffman J., Malick J., Engstrom P. F. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer. 1999 Dec;81(7):1222–1227. doi: 10.1038/sj.bjc.6690832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sauter E. R., Ross E., Daly M., Klein-Szanto A., Engstrom P. F., Sorling A., Malick J., Ehya H. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997;76(4):494–501. doi: 10.1038/bjc.1997.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tafra L., Guenther J. M., Giuliano A. E. Planned segmentectomy. A necessity for breast carcinoma. Arch Surg. 1993 Sep;128(9):1014–1020. doi: 10.1001/archsurg.1993.01420210078010. [DOI] [PubMed] [Google Scholar]
- Wrensch M. R., Petrakis N. L., King E. B., Miike R., Mason L., Chew K. L., Lee M. M., Ernster V. L., Hilton J. F., Schweitzer R. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol. 1992 Jan 15;135(2):130–141. doi: 10.1093/oxfordjournals.aje.a116266. [DOI] [PubMed] [Google Scholar]